Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v2-FR Version v1-EN
Language French English
Date Updated 2025-10-04 2025-10-04
Drug Identification Number 02440709 02440709
Brand name MENJUGATE LIQUID MENJUGATE LIQUID
Common or Proper name Meningococcal Group C Conjugate Vaccine Meningococcal Group C Conjugate Vaccine
Company Name GLAXOSMITHKLINE INC GLAXOSMITHKLINE INC
Ingredients MENINGOCOCCAL GROUP C OLIGOSACCHARIDE CORYNEBACTERIUM DIPHTHERIAE CRM-197 PROTEIN MENINGOCOCCAL GROUP C OLIGOSACCHARIDE CORYNEBACTERIUM DIPHTHERIAE CRM-197 PROTEIN
Strength(s) 10MCG 25MCG 10MCG 25MCG
Dosage form(s) SUSPENSION SUSPENSION
Route of administration INTRAMUSCULAR INTRAMUSCULAR INTRAMUSCULAR INTRAMUSCULAR
Packaging size 10s 10s
ATC code J07AH J07AH
ATC description BACTERIAL VACCINES BACTERIAL VACCINES
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2026-03-31 2026-03-31
Actual discontinuation date
Remaining supply date 2027-05-31 2027-05-31
Discontinuation status To be discontinued To be discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments
Health Canada comments